- Home
- CX vs ASND Comparison
CX vs ASND Comparison
Compare CX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CX
- ASND
- Stock Information
- Founded
- CX 1906
- ASND 2006
- Country
- CX Mexico
- ASND Denmark
- Employees
- CX N/A
- ASND N/A
- Industry
- CX Building Materials
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- CX Industrials
- ASND Health Care
- Exchange
- CX Nasdaq
- ASND Nasdaq
- Market Cap
- CX 12.2B
- ASND 12.0B
- IPO Year
- CX 1999
- ASND 2015
- Fundamental
- Price
- CX $9.23
- ASND $209.64
- Analyst Decision
- CX Buy
- ASND Strong Buy
- Analyst Count
- CX 6
- ASND 16
- Target Price
- CX $9.28
- ASND $240.75
- AVG Volume (30 Days)
- CX 8.0M
- ASND 398.9K
- Earning Date
- CX 10-28-2025
- ASND 11-13-2025
- Dividend Yield
- CX 0.93%
- ASND N/A
- EPS Growth
- CX 856.63
- ASND N/A
- EPS
- CX 0.10
- ASND N/A
- Revenue
- CX $15,675,737,000.00
- ASND $576,332,355.00
- Revenue This Year
- CX $2.64
- ASND $102.31
- Revenue Next Year
- CX $4.82
- ASND $76.44
- P/E Ratio
- CX $8.76
- ASND N/A
- Revenue Growth
- CX N/A
- ASND 54.50
- 52 Week Low
- CX $4.89
- ASND $118.03
- 52 Week High
- CX $9.62
- ASND $214.71
- Technical
- Relative Strength Index (RSI)
- CX 53.22
- ASND 64.93
- Support Level
- CX $8.96
- ASND $187.25
- Resistance Level
- CX $9.13
- ASND $214.71
- Average True Range (ATR)
- CX 0.22
- ASND 6.34
- MACD
- CX -0.03
- ASND 1.37
- Stochastic Oscillator
- CX 58.41
- ASND 84.63
About CX Cemex S.A.B. de C.V. Sponsored ADR
Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.